The FDA's New Vaccine Strategy

When the bivalent COVID boosters against Omicron first came out, only those who had received the initial series of shots were eligible to receive them, but uptake was disappointing. Less than 5% of those eligible had taken a bivalent booster by October 2022, and by late January 2023, that had only risen to 16.2%

Join the World’s #1 Natural Health Newsletter for FREE! Latest Trustworthy News from Dr. Mercola — delivered straight to your inbox!